Here's Why You Should Add DaVita Stock to Your Portfolio Now

DaVita Inc. (DVA) has been gaining from its business model. The optimism, led by a solid second-quarter 2024 performance and the acquisition of dialysis centers, is expected to contribute further. However, concerns regarding its dependence on commercial payers and macroeconomic challenges persist. So far this year, this Zacks Rank #2 (Buy) stock has gained 50.3% compared with the industry's 14.8% growth and the S&P 500's 19.5% increase. The renowned global comprehensive kidney care provider has a market cap ...